Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Фільтри

(Clear all)

Janus Graphene supported Single atom catalysts for ultrasensitive cytokine point of care sensors

RESPONSE

Cytokines, such as TNF-, hold immense significance as protein biomarkers, pivotal for diagnostic, prognostic, and therapeutic management across various clinical disorders like Alzheimers disease, sepsis, and cancer. Nonetheless, prevailing techniques like enzyme-linked immunosorbent assay (ELISA) and Polymerase Chain Reaction (PCR) prove to be...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Janus Graphene supported Single atom catalysts for ultrasensitive cytokine point of care sensors

RESPONSE

Cytokines, such as TNF-, hold immense significance as protein biomarkers, pivotal for diagnostic, prognostic, and therapeutic management across various clinical disorders like Alzheimers disease, sepsis, and cancer. Nonetheless, prevailing techniques like enzyme-linked immunosorbent assay (ELISA) and Polymerase Chain Reaction (PCR) prove to be...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Joint Action on Dementia 2015-2018

Joint Action on Dementia 2015-2018. The Joint Action will focus on two phases on work: approximately 12 months on developing a consensus on the best evidence of effective action in 4 key areas (diagnosis and post-diagnostic support; crisis and care coordination; quality of care in residential care settings; and dementia-friendly communities); and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 498 710

Kinase Regulation by Phase Separation

PhaseKin

Protein phosphorylation is a process that activates biological and cellular pathways. This process is carried out by enzymes called protein kinases that add phosphates to proteins. Protein kinases are crucial drug targets involved in the onset and progression of human diseases such as cancer and Alzheimers disease. Growing evidence suggests that...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 943
European Countries Involved

Knowledge management platform for clinical use of brain data

BrainBase

The connectome is a map of all neural connections in the brain that can provide information about the brain’s (re)wiring in neurological diseases, injuries, or drugs responses. The use of connectomes in clinical practice has enormous potential to improve treatment efficacy, enhance patient stratification, disease characterization, and ultimately...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Label Free Nanoscopy Using Infra Red

LANIR

Every year, Alzheimer's disease (AD) affects about 800,000 new patients in Europe and directly causes 50% of dependency of aged persons. Currently there is no test to diagnose this disease. There is a great need to improve outcomes for patients with lung cancer which causes between 15-28% of all cancer deaths in Europe. Chemical and structural...

Funding Programme
Start Date
End Date
Total Funding
€ 5 456 348
European Countries Involved

Label-free single-molecule detection of complex biomolecule interactions in free motion

LABIMO

Dysregulated interactions between biomolecules can lead to changes in cell signalling and gene expression, both common drivers of human disease. A detailed understanding of these interactions is vital for drug development, often targeting such interactions for therapeutic effects. In this project, I aim to develop an optical microscopy tool to...

Funding Programme
Start Date
End Date
Total Funding
€ 166 278
European Countries Involved

Large scale interactions in brain networks and their breakdown in brain diseases

BRAINSYNC

The long-term goal of this project is to understand how neuronal assemblies exchange information (functional or neuronal communication), and how variability in neuronal communication explains variability in behavioural performance, both in the intact and injured brain. Communication involves temporal interactions between neuronal assemblies either...

Funding Programme
Start Date
End Date
Total Funding
€ 3 933 811
European Countries Involved

Large-scale and wide-band brain dynamics mediating memory consolidation in the freely moving rat

Wide-Band Ephys

Dementia is a major healthcare challenge worldwide due to its high incidence and its strong impact on the life quality of patients and on society as a whole. Development of treatments for the mitigation of memory impairment in patients with dementia has proven very challenging, partly due to our limited understanding of the underlying mechanisms of...

Funding Programme
Start Date
End Date
Total Funding
€ 313 118
European Countries Involved

Light-addressable potentiometric sensors (LAPS) for zinc imaging with high spatiotemporal resolution for elucidating the role of zinc in age related macular degeneration.

ZINCLAPS

Light-addressable potentiometric sensors (LAPS) have great potential as a tool for functional electrochemical imaging of the attachment area of cells, providing information such as ion concentration, extracellular potentials and ion channel activity. The technique is particularly attractive for analysing cell responses of cells with planar...

Funding Programme
Start Date
End Date
Total Funding
€ 195 455
European Countries Involved

Longitudinal multi-omic profiling to provide a molecular map of human stroke

MAP-STROKE

Stroke is a leading and increasingly important cause of death and disability in the EU. Yet, we have only few effective treatments and an unsatisfactory understanding of human stroke pathophysiology. Current diagnostic algorithms fail to capture pathophysiological mechanisms in daily clinical practice, hindering the allocation of patients to...

Funding Programme
Start Date
End Date
Total Funding
€ 202 125
European Countries Involved

Loss of neurotrophic factors in neurodegenerative Dementias: Back to the crossroads of proteins

LODE

Neurodegenerative dementias are characterised by a continuous loss of neurons that are not replaced. Why neurons die in disease-affected brain regions is still a matter of discussion. This project explores a key common pathological mechanism across the three major neurodegenerative diseases leading to dementia: Alzheimer’s disease, Frontotemporal...

Funding Programme
Start Date
End Date
Total Funding
€ 1 020 000
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).